FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2258918132> ?p ?o ?g. }

• W2258918132 abstract "When the ALI in Section 402A enunciated its rule of strict products liability, it swept the country like a prairie fire, or, some thought, locusts. When the Products Liability Restatement was published, its principal critics said it did not restate the law and in fact cut the heart out of the law's expansionary, pro consumer, strict liability tool - Section 402A. Despite the fears of many critics, the elevation of the reasonable alternative design test (which replaced the Prosserian consumer expectations test) did not eviscerate product liability law. Alternative safer design proved to be an effective tool even against tobacco's citadel, while consumer expectations was an unreliable tool even against gun manufacturers who spurned feasible safety devices. Yet the lack of a robust statement of duty, the absence of a clarion call such as the Second Restatement's call for consumer protection made the Products Liability Restatement, as intended, a damper not an accelerant. This article surveys forty years of product liability law and concludes with a call for recognition of a robust common law duty of producers of medical products owed to those who use their products. The duty of product stewardship is centered on an explicit duty of manufacturers to advance the patient's ability to make an informed choice regarding the course of medical treatment. The duty is owed to the patient, not the physician, who is merely an aide of the patient. The approach declares that the manufacturer's duty is to exhaust all reasonable measures to enable the patient and her physician (or other medical service provider) to vindicate the patient's ability to make an informed choice. This patient-centered approach finds the learned intermediary doctrine too narrow. The duty of product stewardship recognizes that the post-market approval stage has been the poorly controlled human experiment stage of product development, as seen with Vioxx, drug-eluting coronary stents, and perhaps Avandia. The duty of product stewardship is patient-centered. It emphasizes the ongoing experimental quality of drugs and other medical products. The experimental nature of (especially) new drugs and devices gives rise to a corresponding duty of product stewardship - a duty of ongoing active study and product development, a duty of systematic manufacturer active post-market surveillance of the actual use of their products after obtaining regulatory approval to market the product." @default.
• W2258918132 created "2016-06-24" @default.
• W2258918132 creator A5072360537 @default.
• W2258918132 date "2007-11-01" @default.
• W2258918132 modified "2023-09-23" @default.
• W2258918132 title "Punctuated Equilibrium: Why §402A Flourished and the Products Liability Restatement Languished" @default.
• W2258918132 hasPublicationYear "2007" @default.
• W2258918132 type Work @default.
• W2258918132 sameAs 2258918132 @default.
• W2258918132 citedByCount "1" @default.
• W2258918132 crossrefType "posted-content" @default.
• W2258918132 hasAuthorship W2258918132A5072360537 @default.
• W2258918132 hasConcept C144133560 @default.
• W2258918132 hasConcept C162324750 @default.
• W2258918132 hasConcept C17744445 @default.
• W2258918132 hasConcept C190253527 @default.
• W2258918132 hasConcept C199286143 @default.
• W2258918132 hasConcept C199539241 @default.
• W2258918132 hasConcept C2524010 @default.
• W2258918132 hasConcept C2777449729 @default.
• W2258918132 hasConcept C2777834853 @default.
• W2258918132 hasConcept C2779103253 @default.
• W2258918132 hasConcept C33923547 @default.
• W2258918132 hasConcept C59149807 @default.
• W2258918132 hasConcept C90673727 @default.
• W2258918132 hasConceptScore W2258918132C144133560 @default.
• W2258918132 hasConceptScore W2258918132C162324750 @default.
• W2258918132 hasConceptScore W2258918132C17744445 @default.
• W2258918132 hasConceptScore W2258918132C190253527 @default.
• W2258918132 hasConceptScore W2258918132C199286143 @default.
• W2258918132 hasConceptScore W2258918132C199539241 @default.
• W2258918132 hasConceptScore W2258918132C2524010 @default.
• W2258918132 hasConceptScore W2258918132C2777449729 @default.
• W2258918132 hasConceptScore W2258918132C2777834853 @default.
• W2258918132 hasConceptScore W2258918132C2779103253 @default.
• W2258918132 hasConceptScore W2258918132C33923547 @default.
• W2258918132 hasConceptScore W2258918132C59149807 @default.
• W2258918132 hasConceptScore W2258918132C90673727 @default.
• W2258918132 hasLocation W22589181321 @default.
• W2258918132 hasOpenAccess W2258918132 @default.
• W2258918132 hasPrimaryLocation W22589181321 @default.
• W2258918132 hasRelatedWork W10086963 @default.
• W2258918132 hasRelatedWork W145690750 @default.
• W2258918132 hasRelatedWork W1520586400 @default.
• W2258918132 hasRelatedWork W1522723902 @default.
• W2258918132 hasRelatedWork W1556232194 @default.
• W2258918132 hasRelatedWork W1562592947 @default.
• W2258918132 hasRelatedWork W1608638993 @default.
• W2258918132 hasRelatedWork W209733449 @default.
• W2258918132 hasRelatedWork W2397127796 @default.
• W2258918132 hasRelatedWork W2402810749 @default.
• W2258918132 hasRelatedWork W2412979412 @default.
• W2258918132 hasRelatedWork W2413127240 @default.
• W2258918132 hasRelatedWork W2765264881 @default.
• W2258918132 hasRelatedWork W2900513799 @default.
• W2258918132 hasRelatedWork W2917896018 @default.
• W2258918132 hasRelatedWork W2950942997 @default.
• W2258918132 hasRelatedWork W3122562977 @default.
• W2258918132 hasRelatedWork W3122634155 @default.
• W2258918132 hasRelatedWork W3138087020 @default.
• W2258918132 hasRelatedWork W325025451 @default.
• W2258918132 isParatext "false" @default.
• W2258918132 isRetracted "false" @default.
• W2258918132 magId "2258918132" @default.
• W2258918132 workType "article" @default.